| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Gustavo Torres de Souza | |
| P2860 | cites work | Production of embryonic and fetal-like red blood cells from human induced pluripotent stem cells | Q21560913 |
| Megakaryocytes derived from embryonic stem cells implicate CalDAG-GEFI in integrin signaling | Q24538576 | ||
| Induced pluripotent stem cell (iPSCs) and their application in immunotherapy | Q26996540 | ||
| Bacterial glycosidases for the production of universal red blood cells | Q27644317 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| In vitro-differentiated embryonic stem cell macrophages: a model system for studying atherosclerosis-associated macrophage functions | Q77380962 | ||
| Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties | Q80521481 | ||
| Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential | Q80579565 | ||
| Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors | Q81015137 | ||
| Directed differentiation of human embryonic stem cells as spin embryoid bodies and a description of the hematopoietic blast colony forming assay | Q81928522 | ||
| In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells | Q82750313 | ||
| iPSCs from cancer cells: challenges and opportunities | Q83948298 | ||
| Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network | Q28252000 | ||
| Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin | Q29619238 | ||
| Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. | Q30489278 | ||
| Decreased immunorejection in unmatched blood transfusions by attachment of methoxypolyethylene glycol on human red blood cells and the effect on D antigen | Q33266929 | ||
| Megakaryocyte development and platelet production. | Q33372021 | ||
| Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells | Q33413336 | ||
| Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders | Q33560423 | ||
| Defined factors induce reprogramming of gastrointestinal cancer cells | Q33591488 | ||
| Erythropoiesis from human embryonic stem cells through erythropoietin-independent AKT signaling | Q33680486 | ||
| Hematopoietic development from human induced pluripotent stem cells | Q33770557 | ||
| Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells | Q33788654 | ||
| Platelets generated from human embryonic stem cells are functional in vitro and in the microcirculation of living mice | Q33789872 | ||
| Human embryonic stem cells: a source of mast cells for the study of allergic and inflammatory diseases | Q33834747 | ||
| Hematopoietic colony-forming cells derived from human embryonic stem cells | Q33943758 | ||
| Biologic properties and enucleation of red blood cells from human embryonic stem cells | Q34013422 | ||
| Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells | Q34233771 | ||
| The promise of induced pluripotent stem cells in research and therapy | Q34248218 | ||
| Induced pluripotent stem cells: past, present, and future | Q34281955 | ||
| Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy | Q34363238 | ||
| Embryonic stem cell-derived M2-like macrophages delay cutaneous wound healing | Q34466816 | ||
| Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion? | Q34614172 | ||
| Concepts of blood transfusion in adults | Q34652259 | ||
| Estimating the cost of blood: past, present, and future directions | Q34655601 | ||
| Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells | Q34732161 | ||
| Efficient, long term production of monocyte-derived macrophages from human pluripotent stem cells under partly-defined and fully-defined conditions | Q34948733 | ||
| Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development | Q35847904 | ||
| Definitive-like erythroid cells derived from human embryonic stem cells coexpress high levels of embryonic and fetal globins with little or no adult globin | Q35848983 | ||
| Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures | Q35849083 | ||
| Directed differentiation of induced pluripotent stem cells towards T lymphocytes | Q36076969 | ||
| Designer blood: creating hematopoietic lineages from embryonic stem cells. | Q36299248 | ||
| Functional characterization of B lymphocytes generated in vitro from embryonic stem cells. | Q36434592 | ||
| Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. | Q37049380 | ||
| An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progression. | Q37053079 | ||
| Generation of functional hemangioblasts from human embryonic stem cells. | Q37154210 | ||
| Generation of induced pluripotent stem cells from human blood | Q37209041 | ||
| Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity | Q37234607 | ||
| Stem cells--a source of adult red blood cells for transfusion purposes: present and future | Q37430686 | ||
| Erythroid cells in vitro: from developmental biology to blood transfusion products | Q37483330 | ||
| Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles | Q38007342 | ||
| Mesodermal and hematopoietic differentiation from ES and iPS cells | Q38017612 | ||
| Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells. | Q38116641 | ||
| A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation | Q38196718 | ||
| Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy | Q38214635 | ||
| Generation of multipotent early lymphoid progenitors from human embryonic stem cells. | Q38982070 | ||
| Clinical-scale derivation of natural killer cells from human pluripotent stem cells for cancer therapy. | Q39177978 | ||
| Two-step differentiation of mast cells from induced pluripotent stem cells | Q39263809 | ||
| Differentiation and characterization of dendritic cells from human embryonic stem cells | Q39303869 | ||
| Human induced pluripotent stem cells are capable of B-cell lymphopoiesis | Q39587756 | ||
| Human pluripotent stem cells produce natural killer cells that mediate anti-HIV-1 activity by utilizing diverse cellular mechanisms | Q39641765 | ||
| Neutrophil differentiation from human‐induced pluripotent stem cells | Q39644354 | ||
| Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells | Q39764925 | ||
| A common bipotent progenitor generates the erythroid and megakaryocyte lineages in embryonic stem cell-derived primitive hematopoiesis. | Q39845785 | ||
| Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures | Q40200355 | ||
| Megakaryocytes derived from human embryonic stem cells: a genetically tractable system to study megakaryocytopoiesis and integrin function. | Q40328019 | ||
| Human embryonic stem cell-derived NK cells acquire functional receptors and cytolytic activity | Q40364711 | ||
| Development of lymphoid lineages from embryonic stem cells in vitro | Q40541080 | ||
| The in vitro differentiation of mouse embryonic stem cells into neutrophils | Q40603769 | ||
| In vitro differentiation of mouse embryonic stem cells to hematopoietic cells on an OP9 stromal cell monolayer | Q40603783 | ||
| In vitro differentiation of mouse embryonic stem cells: hematopoietic and vascular cell types. | Q40603789 | ||
| The in vitro production and characterization of neutrophils from embryonic stem cells | Q40629230 | ||
| Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells | Q40654271 | ||
| The MS-5 murine stromal cell line and hematopoietic growth factors synergize to support the megakaryocytic differentiation of embryonic stem cells. | Q41107612 | ||
| Generation of lymphohematopoietic cells from embryonic stem cells in culture | Q41447884 | ||
| Perspectives on the production of pluripotent cells from hematopoietic cells | Q42958882 | ||
| Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression | Q42972247 | ||
| Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization | Q45864453 | ||
| Hematopoietic commitment of ES cells in culture | Q45871321 | ||
| A genetic strategy to control expression of human blood group antigens in red blood cells generated in vitro | Q46142976 | ||
| Development and functional analysis of eosinophils from murine embryonic stem cells | Q47981247 | ||
| Generation of T cells from human embryonic stem cell-derived hematopoietic zones | Q49134707 | ||
| Robust generation of hemangioblastic progenitors from human embryonic stem cells. | Q50778844 | ||
| In vitro generation of T lymphocytes from embryonic stem cell–derived prehematopoietic progenitors | Q51025580 | ||
| CD34+CD38- hematopoietic precursors derived from human embryonic stem cells exhibit an embryonic gene expression pattern. | Q51037396 | ||
| Derivation of functional mature neutrophils from human embryonic stem cells. | Q51750810 | ||
| Differentiation of mast cells from embryonic stem cells. | Q53176094 | ||
| Definitive proof for direct reprogramming of hematopoietic cells to pluripotency. | Q54475445 | ||
| Generation and characterization of human induced pluripotent stem cells. | Q54477077 | ||
| Differentiation of dendritic cells from human embryonic stem cells | Q57218837 | ||
| Hematopoietic differentiation of embryonic stem cells: an in vitro model to study gene regulation during megakaryocytopoiesis | Q73022961 | ||
| Vascular endothelial growth factor synergistically enhances bone morphogenetic protein-4-dependent lymphohematopoietic cell generation from embryonic stem cells in vitro | Q73584797 | ||
| Production of functional platelets by differentiated embryonic stem (ES) cells in vitro | Q73812286 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 106-15 | |
| P577 | publication date | 2015-01-26 | |
| P1433 | published in | World Journal of Stem Cells | Q27723407 |
| P1476 | title | Advances in cellular technology in the hematology field: What have we learned so far? | |
| P478 | volume | 7 |
Search more.